SCAI 2026 Sirolimus-Eluting Balloons in Coronary PCI: Key Insights from Recent Evidence-Review of SELUTION DeNovo Trial, Dr. Ladwiniec

Review of SELUTION DeNovo Trial, Dr. Ladwiniec

Video Transcription

Video Summary

The speaker discusses a de novo calculation and advances in drug-coated balloon (DCB) and sirolimus-coated balloon technology, noting some progress has been retracted. They emphasize concerns about protocol adherence, stenting versus balloon treatment, and how misclassification affected trial group assignments. The talk highlights learning effects in early cases, suggesting outcomes improved as operators gained experience. The speaker also notes that procedural effort and complexity can vary without necessarily changing clinical results, and that operator performance may have improved by over 30% in some analyses.

Asset Caption

closed captions are computer-generated

Keywords

de novo calculation

drug-coated balloon

sirolimus-coated balloon

protocol adherence

operator learning curve